Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation.

Bryant J, Brodin H, Loveman E, Clegg A.

Int J Technol Assess Health Care. 2007 Winter;23(1):63-70. Review.

PMID:
17234018
2.

Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence.

Lynd LD, O'Brien BJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S99-103. Review.

PMID:
12950529
3.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

4.

Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

Ezekowitz JA, Armstrong PW, McAlister FA.

Ann Intern Med. 2003 Mar 18;138(6):445-52. Review.

PMID:
12639076
5.

The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review.

Bryant J, Brodin H, Loveman E, Payne E, Clegg A.

Health Technol Assess. 2005 Sep;9(36):1-150, iii. Review.

6.

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.

Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, Bryant J.

Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560. Review.

7.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

8.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

9.

Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review.

Parkes J, Bryant J, Milne R.

Health Technol Assess. 2000;4(26):1-69. Review.

10.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

11.

Economic outcomes of implantable cardioverter-defibrillators.

Stanton MS, Bell GK.

Circulation. 2000 Mar 7;101(9):1067-74. Review. Erratum in: Circulation 2000 Jun 20;101(24):2872.

12.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

13.

A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.

Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.

Health Technol Assess. 2008 Jan;12(1):iii-iv, xi-xii, 1-147. Review.

14.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

15.

Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C, McAlister FA.

Ann Intern Med. 2007 Aug 21;147(4):251-62. Review.

PMID:
17709759
16.

The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations.

Gialama F, Prezerakos P, Maniadakis N.

Appl Health Econ Health Policy. 2014 Feb;12(1):41-9. doi: 10.1007/s40258-013-0069-2. Review.

PMID:
24243517
17.
18.

The implantable cardioverter-defibrillator: does everybody need one?

Raj SR, Sheldon RS.

Prog Cardiovasc Dis. 2001 Nov-Dec;44(3):169-94. Review.

PMID:
11727276
20.

Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged?

Daubert JP, Sesselberg HW, Huang DT.

Am J Geriatr Cardiol. 2006 Mar-Apr;15(2):88-92. Review.

PMID:
16525221

Supplemental Content

Support Center